A detailed history of Bridge Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bridge Advisory, LLC holds 805 shares of AMGN stock, worth $250,258. This represents 0.11% of its overall portfolio holdings.

Number of Shares
805
Previous 948 15.08%
Holding current value
$250,258
Previous $273,000 16.48%
% of portfolio
0.11%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $38,448 - $46,412
-143 Reduced 15.08%
805 $228,000
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $25,314 - $28,557
-99 Reduced 9.46%
948 $273,000
Q3 2023

Oct 19, 2023

BUY
$218.65 - $271.46 $228,926 - $284,218
1,047 New
1,047 $281,000
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $205,044 - $238,946
-924 Closed
0 $0
Q4 2020

Feb 26, 2021

BUY
$216.38 - $257.67 $199,935 - $238,087
924 New
924 $213,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bridge Advisory, LLC Portfolio

Follow Bridge Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge Advisory, LLC with notifications on news.